Aridis Pharmaceuticals Inc ARDS:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/23/22 EDT
1.21quote price arrow down-0.02 (-1.63%)
Volume
24,576
52 week range
0.88 - 4.34
Loading...
  • Open1.14
  • Day High1.28
  • Day Low1.13
  • Prev Close1.23
  • 52 Week High4.34
  • 52 Week High Date12/21/21
  • 52 Week Low0.88
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap21.42M
  • Shares Out17.70M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.28
  • YTD % Change-48.07

KEY STATS

  • Open1.14
  • Day High1.28
  • Day Low1.13
  • Prev Close1.23
  • 52 Week High4.34
  • 52 Week High Date12/21/21
  • 52 Week Low0.88
  • 52 Week Low Date05/12/22
  • Market Cap21.42M
  • Shares Out17.70M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.28
  • YTD % Change-48.07

RATIOS/PROFITABILITY

  • EPS (TTM)-3.41
  • P/E (TTM)-0.36
  • Fwd P/E (NTM)-32.70
  • EBITDA (TTM)-11.226M
  • ROE (TTM)-1,000.79%
  • Revenue (TTM)2.98M
  • Gross Margin (TTM)11.68%
  • Net Margin (TTM)-1,528.25%
  • Debt To Equity (MRQ)-39.10%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aridis Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aridis Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs) to treat life-threatening infections. The Company's product pipeline is comprised of fully human mAbs targeting specific pathogens associated with life-threatening bacterial and viral infections, primarily hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP)...
Eric Patzer Ph.D.
Co-Founder, Executive Chairman of the Board
Vu Truong Ph.D.
Chief Executive Officer, Co-Founder, Chief Scientific Officer, Director
Frederick Kurland
Chief Financial Officer
Address
983 University Avenue, Bldg. B
Los Gatos, CA
95032
United States

Top Peers

SYMBOLLASTCHG%CHG
EFTR
eFFECTOR Therapeutics Inc
0.5629+0.0005+0.09%
SNGX
Soligenix Inc
0.5074-0.0315-5.8452%
BCDA
BioCardia Inc
1.86+0.01+0.54%
AIM
AIM ImmunoTech Inc
0.5697-0.0003-0.0526%
ONCR
Oncorus Inc
0.8486-0.036-4.0696%